Wobble Base Bioresearch Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 12717.70%
- Profit Growth 358.30%
- Ebitda -386.96%
- Net Worth 306.46%
- Total Assets 72.27%
About Wobble Base Bioresearch
Wobble Base Bioresearch Private Limited (WBBPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 July 2013 and has a history of 11 years and six months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pratap Mukhopadhyaya and Bharati Mukhopadhyaya serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U73100PN2013PTC148226
- Company No.
148226
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jul 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Wobble Base Bioresearch?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pratap Mukhopadhyaya  | Director | 23-Jul-2013 | Current |
| Bharati Mukhopadhyaya | Director | 23-Jul-2013 | Current |
Financial Performance of Wobble Base Bioresearch.
Wobble Base Bioresearch Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 12717.7% increase. The company also saw a substantial improvement in profitability, with a 358.3% increase in profit. The company's net worth Soared by an impressive increase of 306.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wobble Base Bioresearch?
In 2021, Wobble Base Bioresearch had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sn Genelab Private LimitedPratap Mukhopadhyaya is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Wobble Base Bioresearch?
Unlock and access historical data on people associated with Wobble Base Bioresearch, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wobble Base Bioresearch, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wobble Base Bioresearch's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.